Vulnerability Database · PyPI · accesscontrol · Version

accesscontrol 2.13.12

2.13.12 is affected by 6 vulnerabilities.

The vulnerabilities that cover this exact version are listed below with the fixed version to move to. The upgrade Vulert recommends: 7.5.0.

Critical 1 High 0 Medium 5 Low 0 Unrated 0

Released 31 Oct 2012 Licence ZPL-2.1 Also known from other sources 6 Newer releases 69 Database updated 23/Oct/2026

Release and licence data published by PyPI. Licence information is not legal advice.

Concerned about your application's security?

Vulert continues monitoring your dependencies and alerts you when new vulnerabilities are disclosed. No installation and no source-code access required.

Looking for another version, or everything Vulert holds for accesscontrol?

All versions → Full vulnerability list →

Subscribe to Vulert on Telegram
Daily digest of new CVEs, critical and high severity, affected packages and fixes — plus a weekly roundup.
Join the channel →

Questions

About accesscontrol 2.13.12

Is accesscontrol 2.13.12 vulnerable?

Yes. 6 vulnerabilities in the Vulert database cover accesscontrol 2.13.12: 1 critical, 0 high, 5 medium and 0 low. The upgrade Vulert recommends is 7.5.0, and each entry above names the fixed version to move to.

Which version of accesscontrol should I use instead of 2.13.12?

7.5.0 is the version Vulert recommends for this release line. The version table on the package page lists every release with the vulnerabilities recorded against it.

Is 2.13.12 the latest release of accesscontrol?

No. 2.13.12 was published 31 Oct 2012, and newer releases exist. Newer is not automatically safer — the version table on the package page shows what each release carries.

How do I monitor accesscontrol for upcoming vulnerabilities?

Upload the manifest or SBOM for your application at vulert.com/scanner and Vulert keeps checking the accesscontrol version you actually run against new disclosures, then alerts you when one affects it. There is no installation and no source-code access required.